Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. 21 Sep Continue reading →
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. 08 Jul Continue reading →
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. 08 Jul Continue reading →
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease 08 Jul Continue reading →
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? 22 Nov Continue reading →